Chronic phencyclidine increases NMDA receptor NR1 subunit mRNA in rat forebrain

Journal of Neuroscience Research

Volumn 55, Issue 6, 1999, Pages 762-769

  Wang, Cheng ^a   Showalter, Vincent M ^a   Hillman, Gilbert R ^a   Johnson, Kenneth M ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Behavioral sensitization; Dopamine release; In situ hybridization; Olfactory tubercle; Phencyclidine

Indexed keywords

2 AMINO 5 PHOSPHONOVALERIC ACID; 7 CHLOROKYNURENIC ACID; DOPAMINE; MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PHENCYCLIDINE; RECEPTOR SUBUNIT; TRITIUM;

ANIMAL BEHAVIOR; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINE RELEASE; DRUG ABUSE; FEMALE; FOREBRAIN; IN SITU HYBRIDIZATION; INTRAPERITONEAL DRUG ADMINISTRATION; NEUROTOXICITY; NEUROTRANSMITTER RELEASE; NONHUMAN; OLFACTORY BULB; PRIORITY JOURNAL; RAT; SENSITIZATION;

ANIMALS; CEREBRAL CORTEX; CORPUS STRIATUM; FEMALE; FRONTAL LOBE; MOTOR ACTIVITY; OLFACTORY BULB; PHENCYCLIDINE; PROSENCEPHALON; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; RNA, MESSENGER; SUBSTANCE WITHDRAWAL SYNDROME; TRANSCRIPTION, GENETIC;

EID: 0033559104     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19990315)55:6<762::AID-JNR10>3.0.CO;2-E     Document Type: Article

References (41)

1. Aizenman E, Lipton SA, Loring RH. 1989. Selective modulation of NMDA responses by reduction and oxidation. Neuron 2:1257-1263.
2. Ban TA, Lohrenz JJ, Lehmann HE. 1961. Observations on the action of Sernyl: a new psychotropic drug. Can Psychiatr Assoc J 6:150-156.
3. Bartanusz V, Jezova D, Bertini LT, Tilders FJH, Aubry JM, Kiss JZ. 1993. Stress-induced increase in vasopressin and corticotropin-releasing factor expression in hypophysiotrophic paraventricular neurons. Endocrinology 132:895-902.
4. Castellani S, Adams PM. 1981. Acute and chronic phencyclidine effects on locomotor activity, stereotypy and ataxia in rats. Eur J Pharmacol 73:143-154.
5. Datiche F, Cattarelli M. 1996. Catecholamine innervation of the piriform cortex: A tracing and immunohistochemical study in the rat. Brain Res 710:69-78.
6. Domino EF, Luby E. 1991. Abnormal mental states induced by phencyclidine as a model of schizophrenia. In: Domino EF, editor. PCP (Phencyclidine): historical and current perspectives. Ann Arbor, MI: NPP Books, p 401-418.
7. 3H]norepinephrine release from rat cortical slices. J Pharmacol Exp Ther 253:1138-1144.
8. Grant KA, Valverius P, Hudspith M, Tabakoff B. 1990. Ethanol withdrawal seizures and the NMDA complex. Eur J Pharmacol 176:289-296.
9. Hanania T, Hillman GR, Johnson KM. 1999. Augmentation of locomotor activity by chronic phencyclidine is associated with an increase in striatal NMDA receptor function and an upregulation of the NR1 receptor subunit. Synapse (in press).
10. Hu X-J, Ticku MK. 1995. Chronic ethanol treatment upregulates the NMDA receptor function and binding in mammalian cortical neurons. Mol Brain Res 30:347-356.
11. Hu X-J, Follesa P, Ticku MK. 1996. Chronic ethanol treatment produces a selective upregulation of the NMDA receptor subunit gene expression in mammalian cultured cortical neurons. Mol Brain Res 36:211-218.
12. Ishii T, Mariyoshi K, Sugihara H, Sakurada K, Kadotani H, Yokoi M, Akazawa C, Shigemoto R. Mizuno N, Masu M, Nakanishi S. 1993. Molecular characterization of the family of the N-methyl-D-aspartate receptor subunits. J Biol Chem 268:2836-2843.
13. Itil T, Keskiner A, Kiremitci N, Holden JMC. 1967. Effect of phencyclidine in chronic schizophrenics. Can Psychiatr Assoc J 12:209-212.
14. Javitt DC, Zukin SR. 1991. Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 148:1301-1308.
15. Johnson KM, Balster RL. 1981. Acute and chronic phencyclidine administration: Relationships between biodispositional factors and behavioral effects. Substance Alcohol Actions/Misuse 2:131-142.
16. Johnson KM, Jones SM. 1990. Neuropharmacology of phencyclidine: basic mechanisms and therapeutic potential. Annu Rev Pharmacol Toxicol 30:707-750.
17. Johnson KM, Phillips M, Wang C, Kevetter GA. 1998. Chronic phencyclidine induces behavioral sensitization and apoptotic cell death in the olfactory and piriform cortex. J Neurosci Res 52:709-722.
18. Kumari M, Ticku MK, 1998. Ethanol and regulation of the NMDA receptor subunits in fetal cortical neurons. J Neurochem 70:1467-1473.
19. Lovinger DM, White G, Weight FF. 1989. Ethanol inhibits NMDA-activated ion current in hippocampal neurons. Science 243:1721-1724.
20. Luby ED, Cohen BD, Rosenbaum F, Gottlieb J, Kelley R. 1959. Study of a new schizophrenomimetic drug, Sernyl. Arch Neurol Psychiatry 81:363-369.
21. Lynch DR, Anegawa NJ, Verdoorn T, Pritchett DB, 1994. N-methyl-D-aspartate receptors: different subunit requirements for binding of glutamate antagonists, glycine antagonists, and channel-blocking agents. Mol Pharmacol 45:540-545.
22. McDonald JW, Silverstein FS, Johnston MV. 1990. MK-801 pretreatment enhances N-methyl-D-aspartate brain injury and increases brain N-methyl-D-aspartate recognition site binding in rats. Neuroscience 38:103-113.
23. Melnick SM, Walsh JS, Clark JP, Ettenberg A. 1997. Can the behavioral sensitization to repeated phencyclidine be accounted for by tolerance to the drug's ataxic effects? Soc Neurosci Abstr 23:1093.
24. Moghaddam B, Adams BW. 1998. Reversal of phencylidine effects by a group II metabotropic glutamate recetor agonist in rats. Science 281:1349-1352.
25. Monyer H, Sprengel R, Schoepfer R, Herb A, Higuchi M, Lomeli H, Burnashev N, Sakmann B, Seeburg PH. 1992. Heteromeric NMDA receptors: molecular and functional distinction of subtypes. Science 256:1217-1221.
26. Mori H, Mishina M. 1995. Structure and function of the NMDA receptor channel. Neuropharmacology 34:1219-1237.
27. Moriyoshi K, Masu M, Ishii T, Shigemoto R. Mizuno N, Nakanishi S. 1991. Molecular cloning and characterization of the rat NMDA receptor. Nature 354:31-37.
28. Paxinos G, Watson C. 1986. The rat brain in stereotaxic coordinates, San Diego: Academic Press, p 12-20.
29. Rao TS, Kim HS, Lehmann J, Martin LL, Wood PL. 1990. Interactions of phencyclidine receptor agonist MK-801 with dopaminergic system: regional studies in the rat. J Neurochem 54:1157-1162.
30. 2+ fluxes. Br J Pharmacol 101:178-182.
31. Robinson TE, Berridge KC. 1993. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Rev 18:247-291.
32. Rudolf GD, Cronin CA, Landwehrmeyer GB, Standaert DG, Penney JB, Young AB. 1996. Expression of N-methyl-D-aspartate in the prefrontal cortex of the rat. Neuroscience 93:417-427.
33. A and NMDA receptor function during chronic administration of ethanol. Advances in biochemical psychopharmacology, vol. 47. New York: Raven Press, p 317-324.
34. Standaert DG, Landwehrmeyer GB, Kerner JA, Penney JBJ, Young AB. 1996. Expression of NMDAR2 glutamate receptor subunit mRNA in neurochemically identified interneurons in the rat neostriatum, neocortex and hippocampus. Mol Brain Res 62:89-102.
35. Sturgeon RD, Fessler RG, London SF, Meltzer HY. 1982. Behavioral effects of chronic phencyclidine administration in rats. Psychopharmacology 76:52-56.
36. Trevisan L, Fitzgerald LW, Brose N, Gasic GP, Heinemann SF, Duman RS, Nestler EJ. 1994. Chronic ingestion of ethanol up-regulates NMDARI receptor subunit immunoreactivity in rat hippocampus. J Neurochem 62:1635-1638.
37. Wang C, Johnson KM. 1997. Age- and sex-dependency of phencyclidineinduced behavioral sensitization. Soc Neurosci Abstr 23:192.
38. Williams K, Dichter MA, Molinoff PB. 1992. Up-regulation of N-methyl-D-aspartate receptors on cultured cortical neurons after exposure to antagonists. Mol Pharmacol 42:147-151.
39. Wolf ME, Khansa MR. 1991. Repeated administration of MK-801 produces sensitization to its own locomotor stimulant effects but blocks sensitization to amphetamine. Brain Res 562:164-168.
40. Xu X, Domino EF. 1994a. Phencyclidine-induced behavioral sensitization. Pharmacol Biochem Behav 47:603-608.
41. Xu X, Domino EF. 1994b. Asymmetric cross-sensitization to the locomotor stimulant effects of phencyclidine and MK-801. Neurochem Int 25:155-159.